509 related articles for article (PubMed ID: 16980981)
21. Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis.
Bortolatto J; Borducchi E; Rodriguez D; Keller AC; Faquim-Mauro E; Bortoluci KR; Mucida D; Gomes E; Christ A; Schnyder-Candrian S; Schnyder B; Ryffel B; Russo M
Clin Exp Allergy; 2008 Oct; 38(10):1668-79. PubMed ID: 18631348
[TBL] [Abstract][Full Text] [Related]
22. Live-attenuated Yersinia pestis vaccines.
Wang X; Zhang X; Zhou D; Yang R
Expert Rev Vaccines; 2013 Jun; 12(6):677-86. PubMed ID: 23750796
[TBL] [Abstract][Full Text] [Related]
23. D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague.
Szaba FM; Kummer LW; Wilhelm LB; Lin JS; Parent MA; Montminy-Paquette SW; Lien E; Johnson LL; Smiley ST
Infect Immun; 2009 Oct; 77(10):4295-304. PubMed ID: 19620344
[TBL] [Abstract][Full Text] [Related]
24. [The effect of a modification to the lipopolysaccharide of Yersinia pestis on its neutrophilokine-inducing activity].
Vasil'eva GI; Bespalova IA; Kiseleva AK; Verkina LM; Doroshenko EP; Piatibratov AM
Mikrobiol Z; 1997; 59(2):61-7. PubMed ID: 9221059
[TBL] [Abstract][Full Text] [Related]
25. Construction of defined F1 negative mutants of virulent Yersinia pestis.
Worsham PL; Stein MP; Welkos SL
Contrib Microbiol Immunol; 1995; 13():325-8. PubMed ID: 8833864
[No Abstract] [Full Text] [Related]
26. Distinct biological activity of lipopolysaccharides with different lipid A acylation status from mutant strains of Yersinia pestis and some members of genus Psychrobacter.
Korneev KV; Kondakova AN; Arbatsky NP; Novototskaya-Vlasova KA; Rivkina EM; Anisimov AP; Kruglov AA; Kuprash DV; Nedospasov SA; Knirel YA; Drutskaya MS
Biochemistry (Mosc); 2014 Dec; 79(12):1333-8. PubMed ID: 25716726
[TBL] [Abstract][Full Text] [Related]
27. Yersinia pestis evades TLR4-dependent induction of IL-12(p40)2 by dendritic cells and subsequent cell migration.
Robinson RT; Khader SA; Locksley RM; Lien E; Smiley ST; Cooper AM
J Immunol; 2008 Oct; 181(8):5560-7. PubMed ID: 18832714
[TBL] [Abstract][Full Text] [Related]
28. IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.
Lin JS; Kummer LW; Szaba FM; Smiley ST
J Immunol; 2011 Feb; 186(3):1675-84. PubMed ID: 21172869
[TBL] [Abstract][Full Text] [Related]
29. Pathogenicity of Yersinia pestis synthesis of 1-dephosphorylated lipid A.
Sun W; Six DA; Reynolds CM; Chung HS; Raetz CR; Curtiss R
Infect Immun; 2013 Apr; 81(4):1172-85. PubMed ID: 23357387
[TBL] [Abstract][Full Text] [Related]
30. Potency of killed plague vaccines prepared from avirulent Yersinia pestis.
Williams JE; Altieri PL; Berman S; Lowenthal JP; Cavanaugh DC
Bull World Health Organ; 1980; 58(5):753-6. PubMed ID: 6975184
[TBL] [Abstract][Full Text] [Related]
31. [Effect of monokines induced by Yersinia pestis EV on the functional activity of neutrophils during development of antiplague immunity].
Ivanova IA; Vasil'eva GI; Kiseleva AK
Tsitologiia; 2002; 44(8):799-802. PubMed ID: 12506672
[TBL] [Abstract][Full Text] [Related]
32. Functional characterization and biological significance of Yersinia pestis lipopolysaccharide biosynthesis genes.
Dentovskaya SV; Anisimov AP; Kondakova AN; Lindner B; Bystrova OV; Svetoch TE; Shaikhutdinova RZ; Ivanov SA; Bakhteeva IV; Titareva GM; Knirel AY
Biochemistry (Mosc); 2011 Jul; 76(7):808-22. PubMed ID: 21999543
[TBL] [Abstract][Full Text] [Related]
33. Respiratory immunity is an important component of protection elicited by subunit vaccination against pneumonic plague.
Reed DS; Martinez MJ
Vaccine; 2006 Mar; 24(13):2283-9. PubMed ID: 16377037
[TBL] [Abstract][Full Text] [Related]
34. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS.
Sauter KS; Brcic M; Franchini M; Jungi TW
Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944
[TBL] [Abstract][Full Text] [Related]
35. Attachment of LcrV from Yersinia pestis at dual binding sites to human TLR-2 and human IFN-gamma receptor.
Abramov VM; Khlebnikov VS; Vasiliev AM; Kosarev IV; Vasilenko RN; Kulikova NL; Khodyakova AV; Evstigneev VI; Uversky VN; Motin VL; Smirnov GB; Brubaker RR
J Proteome Res; 2007 Jun; 6(6):2222-31. PubMed ID: 17441749
[TBL] [Abstract][Full Text] [Related]
36. A horizontally acquired filamentous phage contributes to the pathogenicity of the plague bacillus.
Derbise A; Chenal-Francisque V; Pouillot F; Fayolle C; Prévost MC; Médigue C; Hinnebusch BJ; Carniel E
Mol Microbiol; 2007 Feb; 63(4):1145-57. PubMed ID: 17238929
[TBL] [Abstract][Full Text] [Related]
37. A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model.
Gregg KA; Harberts E; Gardner FM; Pelletier MR; Cayatte C; Yu L; McCarthy MP; Marshall JD; Ernst RK
Vaccine; 2018 Jun; 36(28):4023-4031. PubMed ID: 29861179
[TBL] [Abstract][Full Text] [Related]
38. Kinetics of the immune response to the (F1+V) vaccine in models of bubonic and pneumonic plague.
Williamson ED; Stagg AJ; Eley SM; Taylor R; Green M; Jones SM; Titball RW
Vaccine; 2007 Jan; 25(6):1142-8. PubMed ID: 17101198
[TBL] [Abstract][Full Text] [Related]
39. [Toxicity and cytokine-inducing activity of lipopolysaccharide of virulent Yersinia pestis 231 strain].
Sokolova EP; Demidova GV; Ziuzina VP; Borodina TN; Bespalova IA; Alekseeva LP; Tynianova VI
Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):20-6. PubMed ID: 22308722
[TBL] [Abstract][Full Text] [Related]
40. R-form LPS, the master key to the activation ofTLR4/MD-2-positive cells.
Huber M; Kalis C; Keck S; Jiang Z; Georgel P; Du X; Shamel L; Sovath S; Mudd S; Beutler B; Galanos C; Freudenberg MA
Eur J Immunol; 2006 Mar; 36(3):701-11. PubMed ID: 16506285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
